Abstract

Background and Objective:The Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 grading classification has been used to evaluate the severity of patients with chronic obstructive pulmonary disease (COPD). However, little is known about the relationship between the systemic inflammation and this classification. We aimed to study the relationship between serum CRP and the components of the GOLD 2011 grading classification.Methods:C-reactive protein (CRP) levels were measured in 391 clinically stable COPD patients and in 50 controls from June 2, 2015 to October 31, 2015 in the First Affiliated Hospital of Xiamen University. The association between CRP levels and the components of the GOLD 2011 grading classification were assessed.Results:Correlation was found with the following variables: GOLD 2011 group (0.240), age (0.227), pack year (0.136), forced expiratory volume in one second % predicted (FEV1%; -0.267), forced vital capacity % predicted (-0.210), number of acute exacerbations in the past year (0.265), number of hospitalized exacerbations in the past year (0.165), British medical Research Council dyspnoea scale (0.121), COPD assessment test score (CAT, 0.233). Using multivariate analysis, FEV1% and CAT score manifested the strongest negative association with CRP levels.Conclusions:CRP levels differ in COPD patients among groups A-D based on GOLD 2011 grading classification. CRP levels are associated with several important clinical variables, of which FEV1% and CAT score manifested the strongest negative correlation.

Highlights

  • Chronic obstructive pulmonary disease (COPD) is one of the major global health issues of the century

  • In the present study, we aimed to evaluate whether the levels of C-reactive protein (CRP) in chronic obstructive pulmonary disease (COPD) patients is associated with the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2011 grading classification

  • There is no ideal disease-specific biomarker which can represent the systemic inflammation in COPD patients

Read more

Summary

Introduction

Chronic obstructive pulmonary disease (COPD) is one of the major global health issues of the century It affects about 10% of the population over the age of 40 years[1] and it is predicted to be the third leading cause of death and disability in the world by 2020.2 The updated version of 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) proposed crucial changes to the stratification of COPD patients.[3] The new COPD assessment integrates a combined assessment of clinical symptoms, severity of airflow limitation, and future risks of exacerbation, classifying patients into groups A-D. CRP levels are associated with several important clinical variables, of which FEV1% and CAT score manifested the strongest negative correlation

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call